Ergoteles’s Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant CPUH.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,200
Closed -$199K 2151
2022
Q2
$199K Hold
20,200
0.01% 1336
2022
Q1
$200K Hold
20,200
0.01% 998
2021
Q4
$201K Hold
20,200
0.01% 1036
2021
Q3
$202K Hold
20,200
0.01% 999
2021
Q2
$206K Hold
20,200
﹤0.01% 1268
2021
Q1
$204K Buy
+20,200
New +$212K 0.01% 665

Other funds holding CPUH.U

Ergoteles's CPUH.U Position: Q3 2022 in Review

Ergoteles sold out of Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant (CPUH.U) in Q3 2022, closing a stake of 20,200 shares — an estimated $199K sold.

Ergoteles first reported a position in CPUH.U in Q1 2021 and held it in 6 quarters. The position peaked at $206K in Q2 2021. 32 funds tracked by Wall St. Rank hold CPUH.U as of Q3 2022.

  • Ergoteles reported no remaining Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position as of Q3 2022 after selling out during the quarter.
  • Ergoteles sold 20,200 Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant shares in Q3 2022, an estimated $199K.
  • Ergoteles first reported a position in Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant in Q1 2021 and held it in 6 quarters.
  • Ergoteles's Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position peaked at $206K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.